Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | APAF1 | O14727 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 15/20 | 0.40 |
| ▸ | PON1 | P27169 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17131173 | 0.95 | MEN1 (0.53) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL17131175 | 0.93 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL3771778 | 0.89 | FDPS (0.38) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL3772289 | 0.85 | MEN1 (0.49) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5328624 | 0.85 | MEN1 (0.50) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5333129 | 0.85 | MEN1 (0.50) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5329865 | 0.85 | MEN1 (0.50) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5333419 | 0.85 | MEN1 (0.50) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5332000 | 0.85 | MEN1 (0.50) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL2428369 | 0.83 | MEN1 (0.41) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11996557-B2 | Direct regeneration of lithium ion cathodes by ionothermal relithiation | UT-BATTELLE, LLC (US) | 2024-05-28 | — | — | US | disclosed |
| US-20230378459-A1 | SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| US-11795583-B2 | Plasticized melt spinning process using ionic liquids for production of polyacrylonitrile fibers | UT-BATTELLE, LLC (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230327207-A1 | Storage Battery, Battery Control Unit, and Electronic Device | SEMICONDUCTOR ENERGY LAB (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230231199-A1 | SECONDARY BATTERY AND VEHICLE INCLUDING SECONDARY BATTERY | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20220376240-A1 | DIRECT REGENERATION OF LITHIUM ION CATHODES BY IONOTHERMAL RELITHIATION | U. S. DEPARTMENT OF ENERGY | 2022-11-24 | — | — | US | disclosed |
| US-20220235493-A1 | PLASTICIZED MELT SPINNING PROCESS USING IONIC LIQUIDS FOR PRODUCTION OF POLYACRYLONITRILE FIBERS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2022-07-28 | — | — | US | disclosed |
| US-11251433-B2 | Nitrogen-sulfur-carbon nanocomposites and their application as cathode materials in lithium-sulfur batteries | UT-BATTELLE, LLC (US) | 2022-02-15 | — | — | US | disclosed |
| US-11186893-B2 | Rare earth amide compositions | UT-BATTELLE, LLC (US) | 2021-11-30 | — | — | US | disclosed |
| US-20200370144-A1 | METHODS FOR LIQUID EXTRACTION OF RARE EARTH METALS USING IONIC LIQUIDS | UT-BATTELLE, LLC (US) | 2020-11-26 | — | — | US | disclosed |
| US-20150279577-A1 | POWER STORAGE DEVICE AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-8865094-B2 | Methods for separating medical isotopes using ionic liquids | UT-BATTELLE, LLC (US) | 2014-10-21 | — | — | US | disclosed |
| US-20140141328-A1 | NITROGEN-SULFUR-CARBON NANOCOMPOSITES AND THEIR APPLICATION AS CATHODE MATERIALS IN LITHIUM-SULFUR BATTERIES | UT-BATTELLE, LLC (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140113202-A1 | ELECTROLYTE COMPOSITIONS FOR LITHIUM ION BATTERIES | UT-BATTELLE, LLC (US) | 2014-04-24 | — | — | US | disclosed |
| US-20140072485-A1 | METHODS FOR SEPARATING MEDICAL ISOTOPES USING IONIC LIQUIDS | UT-BATTELLE, LLC (US) | 2014-03-13 | — | — | US | disclosed |
| US-8585886-B2 | Method for synthesis of titanium dioxide nanotubes using ionic liquids | UT-BATTELLE, LLC (US) | 2013-11-19 | — | — | US | disclosed |
| US-20130280151-A1 | IONIC LIQUID-FUNCTIONALIZED MESOPOROUS SORBENTS AND THEIR USE IN THE CAPTURE OF POLLUTING GASES | U.S. DEPARTMENT OF ENERGY | 2013-10-24 | — | — | US | disclosed |
| US-20120175266-A1 | METHOD FOR SYNTHESIS OF TITANIUM DIOXIDE NANOTUBES USING IONIC LIQUIDS | UT-BATTELLE, LLC (US) | 2012-07-12 | — | — | US | disclosed |
| US-20100311615-A1 | METHOD FOR SYNTHESIS OF TITANIUM DIOXIDE NANOTUBES USING IONIC LIQUIDS | UT-BATTELLE, LLC (US) | 2010-12-09 | — | — | US | disclosed |
| US-20060186419-A1 | Light-emitting device | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230378459-A1 | SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE | VDAC3, VDAC2, SCO2 | MEN1 2332/4885HSP90AA1 2985/4885KMT2A 1910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.